Life Science REIT PLC
LSE:LABS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Life Science REIT PLC
Cash from Financing Activities
Life Science REIT PLC
Cash from Financing Activities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
L
|
Life Science REIT PLC
LSE:LABS
|
Cash from Financing Activities
-£5.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Primary Health Properties PLC
LSE:PHP
|
Cash from Financing Activities
£301m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Assura PLC
LSE:AGR
|
Cash from Financing Activities
£196.3m
|
CAGR 3-Years
-21%
|
CAGR 5-Years
14%
|
CAGR 10-Years
N/A
|
|
|
Target Healthcare REIT PLC
LSE:THRL
|
Cash from Financing Activities
-£82.3m
|
CAGR 3-Years
-49%
|
CAGR 5-Years
-66%
|
CAGR 10-Years
N/A
|
|
Life Science REIT PLC
Glance View
Life Science Reit Plc is an investment company, which intends to carry on business as a REIT. The Company’s investment objective is to provide shareholders with a level of total return. The company will seek to achieve its investment objective by investing in a diversified portfolio of properties across the United Kingdom which are leased or intended to be leased to tenants operating in, or providing a benefit to, the life science sector. The company acquires or develops properties, such as wet and dry laboratories, offices, incubators and co-working space, manufacturing and testing facilities and data centers. The company acquires individual buildings, a group of buildings across a single science park or the entirety of a science park. This may include purchasing or developing buildings that are leased or intended to be leased to tenants providing ancillary services to employees of companies operating in, or providing a benefit to, the life science sector. The Company’s investment adviser is Ironstone Asset Management Limited.
See Also
What is Life Science REIT PLC's Cash from Financing Activities?
Cash from Financing Activities
-5.3m
GBP
Based on the financial report for Dec 31, 2024, Life Science REIT PLC's Cash from Financing Activities amounts to -5.3m GBP.
What is Life Science REIT PLC's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 1Y
80%
Over the last year, the Cash from Financing Activities growth was 80%.